Last $327.58 USD
Change Today +0.70 / 0.21%
Volume 1.1M
BIIB On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 8:10 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John G. Cox

Executive Vice President of Pharmaceutical Operations & Technology, Biogen Idec Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 3 different industries.

See Board Relationships
51$3,671,597
As of Fiscal Year 2013

Background*

Mr. John G. Cox has been an Executive Vice President of Pharmaceutical Operations & Technology at Biogen Idec Inc. and Biogen Idec Ltd. since June 2010. Mr. Cox oversees Biogen Idec's global manufacturing, technical development, supply chain, engineering and facilities operations across the globe. He joined Biogen Idec in 2003 and served as its Senior Vice President of Global Manufacturing and Operations. He served senior operational roles at Covance Biotech and American ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 781-464-2000
Fax: --

Board Members Memberships*

2013-Present
Director

Education*

MBA
University of Michigan
MS
California State University
BS
Arizona State University-Tempe

Other Affiliations*

Annual Compensation*

Salary$625,648
Total Annual Compensation$625,648

Stock Options*

Restricted Stock Awards$2,247,885
All Other Compensation$201,061
Exercisable Options15,546
Exercisable Options Value$3,460,740
Total Value of Options$3,460,740
Total Number of Options15,546

Total Compensation*

Total Annual Cash Compensation$1,417,982
Total Short Term Compensation$625,648
Other Long Term Compensation$2,448,946
Total Calculated Compensation$3,671,597
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB:US $327.58 USD +0.70

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc N. Casper Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee
Thermo Fisher Scientific, Inc.
$1.1M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN IDEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.